HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
INSIDE INDUSTRY
Agilent Technologies Collaborates with Florey Institute of Neuroscience and Mental Health
Agilent Technologies Inc. has collaborated with the Florey Institute of Neuroscience and Mental Health to allow scientists to detect and measure metals at the protein level directly from tissue in neurodegenerative diseases such as motor neuron, Parkinson's and Alzheimer's.

For scientists and researchers, the ability to monitor and measure a set of proteins that have metal-binding capacity (metalloproteins) could lead to significant advances in their understanding of disease mechanisms and normal biological processes. Unlocking the role of metalloproteins will provide a more complete picture of what goes wrong during disease processes. This understanding could create new opportunities to develop therapies that target specific metalloprotein dysfunction.

“This is an important breakthrough for the scientific community as we push forward for more effective treatments for a range of neurological and psychiatric conditions,” said Dr. Blaine Roberts, senior research scientist at the Florey Institute of Neuroscience and Mental Health.

Scientists recognize that a role for metals in neurodegenerative disease exists but have been able to secure very little molecular detail at the protein level for how changes in the levels of metals such as copper, iron or zinc translate to altered cellular function and disease.

“We are very excited about this collaboration, as it matches the leading-edge brain research of the Florey's and Agilent's leading-edge technologies,” said Rod Minett, general manager of Agilent's Life Sciences Group in South Korea and the South Asia-Pacific region. “The emerging field of metalloproteins will help us better understand the human brain and could potentially lead to better clinical outcomes for patients.”

The Metalloproteomics Laboratory at the Florey specializes in quantitatively determining the changes of metalloproteins directly from biological material using liquid chromatography techniques coupled with the Agilent 7700 ICP-MS (inductively coupled plasma mass spectrometry). These techniques allow scientists to conduct direct comparison of metalloproteins quickly, produce detailed metalloprotein maps and, most important, reveal the range and complexity of metalloproteins that exist in those biological samples.

“The study of metal-protein interactions and of the biological activity of metalloproteins is critical for understanding how biological systems work,” said Dr. Rudolf Grimm, Agilent's director of science and technology and manager of collaborations in the Asia-Pacific region. “This collaboration will help strengthen Agilent's position in the academic research market.”

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy